<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>http://wikikurgan.ru/index.php?action=history&amp;feed=atom&amp;title=Doxorubicin_For_Learners</id>
	<title>Doxorubicin For Learners - История изменений</title>
	<link rel="self" type="application/atom+xml" href="http://wikikurgan.ru/index.php?action=history&amp;feed=atom&amp;title=Doxorubicin_For_Learners"/>
	<link rel="alternate" type="text/html" href="http://wikikurgan.ru/index.php?title=Doxorubicin_For_Learners&amp;action=history"/>
	<updated>2026-10-15T02:22:41Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.31.8</generator>
	<entry>
		<id>http://wikikurgan.ru/index.php?title=Doxorubicin_For_Learners&amp;diff=2154450&amp;oldid=prev</id>
		<title>Gander56orange: Новая страница: «? 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 30:443�C447, 2012 &quot;&quot;Degeneration of the intervertebral disc (IVD) results …»</title>
		<link rel="alternate" type="text/html" href="http://wikikurgan.ru/index.php?title=Doxorubicin_For_Learners&amp;diff=2154450&amp;oldid=prev"/>
		<updated>2017-02-17T05:35:15Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «? 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 30:443�C447, 2012 &amp;quot;&amp;quot;Degeneration of the intervertebral disc (IVD) results …»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;? 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 30:443�C447, 2012 &amp;quot;&amp;quot;Degeneration of the intervertebral disc (IVD) results in deterioration of the spinal motion segment and can lead to debilitating back pain. Given the established mitotic and anti-apoptotic effects of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in a variety of cell types we postulated that rhPDGF-BB might delay disc cell degeneration through inhibition [https://en.wikipedia.org/wiki/BML-190 BML-190] of apoptosis. To address this hypothesis, we treated human IVD cells isolated from five independent patients with rhPDGF-BB in monolayer and 3D pellet cultures. The anti-apoptotic potential, cell proliferative capacity, morphology/pellet differentiation, and gene expression of PDGF-treated IVD cells were evaluated via flow cytometry/immunohistochemistry, MTT assays, histology, and quantitative RT-PCR, respectively. We found that rhPDGF-BB treatment significantly inhibited cell apoptosis, increased cell proliferation and matrix production, and maintained mRNA expression of critical extracellular matrix genes. This study suggests two possible mechanisms for the anti-degenerative effects of rhPDGF-BB on human IVD cells. First, PDGF treatment strongly inhibited IVD cell apoptosis in 3D cultures. Second, rhPDGF-BB acts as an anabolic agent, promoting maintenance of IVD cell phenotype in 3D culture, based on the molecular and protein expression analysis. We speculate that rhPDGF-BB may be used as a biologic treatment to target early degenerative IVD disease in the future. ? 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:1181�C1188, [http://www.selleckchem.com/products/Adriamycin.html Doxorubicin cell line] 2014. &amp;quot;&amp;quot;Minimally invasive and non-destructive methods to quantify glycosaminoglycans (GAGs) in articular cartilage extracellular matrix are of significant interest for the biochemical analysis of cartilage and diagnosis and tracking of osteoarthritis in vivo. Here, we report the use of cationic iodinated contrast agents in comparison [http://www.selleckchem.com/products/DAPT-GSI-IX.html DAPT in vivo] to conventional anionic contrast agents for the quantitative monitoring of GAG concentrations with peripheral quantitative computed tomography. Using an ex vivo bovine osteochondral plug model, the cationic contrast agents were evaluated for their ability to distribute into articular cartilage and generate a positive relationship with GAG content. The cationic agents resulted in much higher equilibrium X-ray attenuations in cartilage extracellular matrix (ECM) than anionic agents. Experiments with samples subjected to enzymatic GAG degradation demonstrated that the cationic agents were up to five times more sensitive (p?=?0.0001) to changes in GAG content and had a 24% higher correlation (p?=?0.002) compared to the anionic agent (R2?=?0.86, p?&lt;/div&gt;</summary>
		<author><name>Gander56orange</name></author>
		
	</entry>
</feed>